VIA-3196

· Madrigal Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VIA-3196, covering 2012-12-06 to 2012-12-06. Get the full timeline:

Most recent: Clinical Trial Update: Ascending Multiple-Dose Study to Evaluate VIA-3196 in Healthy Subjects [Phase 1]